头颈癌患者门诊加速胃造瘘管置入的多学科协作路径:单中心回顾性研究
本研究回顾性纳入2015至2022年接受影像引导胃造瘘管置入的142例头颈癌患者,其中52例经传统路径、90例经加速路径。加速路径使从会诊到操作的时间缩短11.1天(95%CI 7.6-14.6,P<0.001),每次操作费用降低2940美元(95%CI 989-4891,P<0.001),两组90天并发症发生率无显著差异(传统组32.7% vs 加速组22.2%,P=0.17)。
要点
- 加速路径较传统路径从会诊到操作时间缩短11.1天(95%CI 7.6-14.6,P<0.001)。
- 加速路径每次操作费用较传统路径降低2940美元(95%CI 989-4891,P<0.001)。
- 两组90天并发症发生率无显著差异(传统组32.7% vs 加速组22.2%,P=0.17)。
核心结论
- 由介入放射科、头颈肿瘤内外科、营养科和言语语言病理科组成的多学科团队实施的门诊加速胃造瘘管置入路径,较本机构既往做法能更快提供肠内营养支持、降低相关费用并更具患者中心性。
研究设计与样本
- 单中心回顾性研究,纳入2015至2022年接受择期影像引导胃造瘘管置入的142例头颈癌患者,传统路径52例、加速路径90例,比较围手术期费用和90天并发症率。
诊断标准与关键数值
- 90天并发症发生率:传统路径组32.7% vs 加速路径组22.2%,P=0.17,两组无显著差异。
- 从会诊到操作时间:加速路径较传统路径缩短11.1天(95%CI 7.6-14.6,P<0.001)。
- 每次操作费用:加速路径较传统路径降低2940美元(95%CI 989-4891,P<0.001)。
临床应用与阅片要点
- 作者所在机构通过介入放射科、头颈肿瘤内外科、营养科和言语语言病理科组成的多学科团队实施门诊加速胃造瘘管置入路径。
- 该路径在90天并发症率与传统路径无显著差异的前提下,缩短了从会诊到操作的时间并降低了每次操作费用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVE: Treatment for head and neck cancer (HNC) can lead to decreased oral intake which often requires gastrostomy tube (g-tube) placement to provide nutritional support. A multidisciplinary team (MDT) consisting of interventional radiology (IR), HNC oncology and surgery, nutrition, and speech language pathology departments implemented an expedited outpatient g-tube placement pathway to reduce hospital stays and associated costs, initiate feeds sooner, and improve communication between care teams. This single center study investigates differences in complications, time to procedure and costs savings with implementing this pathway.
METHODS: 142 patients with HNC who underwent elective image guided g-tube placement by IR from 2015 to 2022 were identified retrospectively. 52 patients underwent the traditional pathway, and 90 patients underwent the expedited pathway. Patient demographics, procedure characteristics, periprocedural costs and 90-day complication rates were collected and compared statistically.
RESULTS: The 90-day complication rate was comparable between groups (traditional=32.7%; expedited=22.2%; p-value=0.17). The expedited pathway decreased the time from consult to procedure by 11.1 days (95% CI 7.6 - 14.6; p < 0.001) and decreased charge per procedure by $2940 (95% CI $989-$4891; p < 0.001).
CONCLUSION: A MDT for the treatment of patients with HNC successfully provided enteral nutrition support faster, with fewer associated costs, and in a more patient centered approach than previously done at this institution.
引用
- Haldeman PB, Ghani MA, Rubio P, et al. Interdisciplinary Approach to Expedited Outpatient Gastrostomy Tube Placement in Head and Neck Cancer Patients: A Single Center Retrospective Study. Acad Radiol. 2024. PMID: 38521613. doi:10.1016/j.acra.2024.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。